Centerline Biomedical

Centerline Biomedical

Financials

Estimates*

Edit
Revenues, earnings & profits over time
USD20192020202120222023
Revenues<1m2.2m3.9m4.5m4.5m
% growth-167 %77 %15 %-
  • Edit

Recent News about Centerline Biomedical

Edit
More about Centerline Biomedicalinfo icon
Edit

Centerline Biomedical, a spin-off from the Cleveland Clinic, specializes in advanced surgical navigation technology. The company's flagship product, the Intra Operative Positioning System (IOPS), is a 3D GPS-like system designed to enhance surgical precision, simplify complex procedures, and reduce radiation exposure for both patients and healthcare professionals. Operating primarily in the healthcare sector, Centerline Biomedical serves hospitals, surgical centers, and medical professionals who perform endovascular procedures. The business model revolves around the sale and licensing of its proprietary technology, along with providing ongoing support and training services. Revenue is generated through direct sales, licensing agreements, and service contracts. Centerline Biomedical's market includes healthcare institutions looking to improve surgical outcomes and patient safety through cutting-edge technology.

Keywords: 3D navigation, surgical precision, endovascular, healthcare technology, radiation reduction, Cleveland Clinic, IOPS, medical innovation, surgical support, patient safety.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.